We can highlight the next thriving fund investment areas, such as Biopharma, Biotechnology. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Aura Biosciences, SANIFIT, Vivet Therapeutics. Besides, a startup needs to be aged 11-15 years to get the investment from the fund.
The important activity for fund was in 2017. The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. Considering the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations.
The usual cause for the fund is to invest in rounds with 7-8 partakers. Despite the Columbus Venture Partners, startups are often financed by Ysios Capital, Caixa Capital Risc, la Caixa. The meaningful sponsors for the fund in investment in the same round are Ysios Capital, Lundbeckfonden Ventures, Roche Venture Fund. In the next rounds fund is usually obtained by Pfizer, Medicxi Ventures.
We also calculated 2 valuable employees in our database.
| Fund Name | Location |
| BRANDED STRATEGIC ADVISORS | New York, New York, United States |
| CDAM | England, London, United Kingdom |
| Falcon Partners | New Jersey, Roseland, United States |
| Frontier International | Japan, Tokyo |
| Google Cloud Platform | California, San Francisco, United States |
| Hatzimemos / Libby | New York, New York, United States |
| ITC Holdings | Michigan, Novi, United States |
| J21 Corporation | Japan, Tokyo |
| Japan-Portal | - |
| Jynwel Capital | China, Hong Kong, Hong Kong Island |
| Miroma Ventures | California, Los Angeles, United States |
| NJR Clean Energy Ventures | Belmar, New Jersey, United States |
| OCCIDENT | Switzerland, Zug, Zug |
| Robolution Capital | France, Ile-de-France, Paris |
| ShopHQ | Eden Prairie, Minnesota, United States |
| Southern Pacific Capital Group | Florida, Melbourne, United States |
| Stone-Goff Partners | Boston, Massachusetts, United States |
| The Barton Partnership | England, London, United Kingdom |
| Venture Farmers | - |
| W3 Digital Agency | Argentina, Buenos Aires, Distrito Federal |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Multiverse Computing | $29M | 05 Mar 2024 | San Sebastián, Autonomous Community of the Basque Country, Spain | ||
Curve Therapeutics | $55M | 27 Feb 2024 | Southampton, Hampshire, United Kingdom | ||
ARTHEx Biotech | $49M | 03 May 2023 | Valencia, Valencian Community, Spain | ||
Minoryx Therapeutics | $60M | 31 May 2022 | Barcelona, Catalonia, Spain | ||
Integra Therapeutics | $1M | 29 Mar 2022 | Barcelona, Catalonia, Spain | ||
NeRRe Therapeutics | $27M | 07 Jul 2021 | United Kingdom, England, United Kingdom | ||
Artax Biopharma | 04 Jun 2020 | Cambridge, Massachusetts, United States | |||
Aura Biosciences | $30M | 21 Dec 2017 | Cambridge, Massachusetts, United States | ||
Vivet Therapeutics | $44M | 04 May 2017 | Paris, Ile-de-France, France |
– Aura Biosciences closed an oversubscribed $80m financing.
– The financing was led by Matrix Capital Management and Surveyor Capital (a Citadel company) with participation from new investors, including Rock Springs Capital, Adage Capital Management LP and Velosity Capital.
– Existing investors Medicxi, Advent Life Sciences, Lundbeckfonden Ventures, Arix Bioscience, Chiesi Ventures, Ysios Capital and Columbus Venture Partners also participated in the round.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Multiverse Computing | $29M | 05 Mar 2024 | San Sebastián, Autonomous Community of the Basque Country, Spain | ||
Curve Therapeutics | $55M | 27 Feb 2024 | Southampton, Hampshire, United Kingdom | ||
ARTHEx Biotech | $49M | 03 May 2023 | Valencia, Valencian Community, Spain | ||
Minoryx Therapeutics | $60M | 31 May 2022 | Barcelona, Catalonia, Spain | ||
Integra Therapeutics | $1M | 29 Mar 2022 | Barcelona, Catalonia, Spain | ||
NeRRe Therapeutics | $27M | 07 Jul 2021 | United Kingdom, England, United Kingdom | ||
Artax Biopharma | 04 Jun 2020 | Cambridge, Massachusetts, United States | |||
Aura Biosciences | $30M | 21 Dec 2017 | Cambridge, Massachusetts, United States | ||
Vivet Therapeutics | $44M | 04 May 2017 | Paris, Ile-de-France, France |
